Matthew Herder considers possible regulatory responses to the opioid epidemic that aim to recover health care costs, compensate survivors, or prosecute pharmaceutical companies.
Martha Paynter reasons that the parent-infant benefits of breastfeeding/chestfeeding outweigh concerns about drug regimens that facilitate transgender women’s lactation.
Paul Austin advocates for increased government funding of psychedelic therapy research, which can transform the way we understand and treat mental health conditions.
Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.
Chelsea Cox explores the financial and ethical implications of Canada’s upcoming legalization of marijuana.